A classification scheme is presented to discuss the biological behavio
r of canine malignant skeletal neoplasms and their response to treatme
nt. Osteosarcoma of the appendicular skeleton is the prototypical cani
ne skeletal neoplasm, accounting for about 80 % of primary bone tumors
. Local tumor control is readily achieved in dogs with appendicular os
teosarcoma; inadequate treatment of metastatic disease is responsible
for mortality. Osteosarcoma of the axial skeleton is discussed as a se
parate clinical entity because there is very limited information on th
e biological behavior of these neoplasms after successful local tumor
control. Collectively, the non-osteogenic primary bone sarcomas repres
ent a third important group of canine skeletal neoplasms. Bone metasta
ses and fracture-associated sarcoma are grouped together because they
account for the majority of skeletal neoplasms that affect the diaphys
is of long bones (in contrast to the metaphyseal location of most prim
ary bone sarcomas). Finally, skeletal neoplasms of small dogs (body we
ight less than 15 kg) are discussed as a separate entity because of di
stinct differences in histopathological type and site distribution com
pared to the bone tumors of large and giant breed dogs.